Official UK procurement notice
Vagal Nerve Stimulator (VNS)
Authority: NWSSP Cardiff and Vale Local Health Board
What is being bought
Published requirement descriptionThe Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised.
Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.
CPV: Stimulator
The lotProcurement structure
single lot · no lot value publishedLot #1As stated in the description aboveAwarded
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 14 Feb 2023, 15:57 GMT
- Last source update
- 23 Jan 2024, 12:57 GMT
- Authority reference
CAV-DCO (22-23) 147- FTS notice number
2024/S 000-002248- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03a5a5Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Livanova hold the patent for VSN products and therefore have a monopoly of the global market. Due to this, the Health Board have no other option than to award a contract direct to Livanova UK Limited as these products are the only items that can reduce and/or prevent seizures for patients.
Publisher note: (WA Ref:132472)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| LivaNova UK Ltd | £600,000 †same award published again · counted once | — | Awarded |
| LivaNova UK Ltd | £600,000 † | — | Awarded |
Contracts
Contract 002248-2024-CAV-DCO (22-23) 147-1 · LivaNova UK Ltd
- Signed
- 14 Feb 2023
- Value
- £600,000
- Status
- active
Contract 004559-2023-CAV-DCO (22-23) 147-1 · LivaNova UK Ltd
- Signed
- 14 Feb 2023
- Value
- £600,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 0 electronic | 1 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- LivaNova UK LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.